Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primates
- 30 November 1992
- journal article
- Published by Elsevier in International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology
- Vol. 19 (8) , 881-888
- https://doi.org/10.1016/0883-2897(92)90174-w
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Dynamic SPECT imaging after injection of the benzodiazepine receptor ligand [123I]iomazenil in healthy human subjectsPsychiatry Research: Neuroimaging, 1992
- A simple method for the preparation of 123I and 125I labeled iodobenzodiazepinesInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1991
- SPECT imaging of the benzodiazepine receptor in non-human primate brain with [123I]Ro 16-0154European Journal of Pharmacology, 1991
- Receptor binding characterization of the benzodiazepine radioligand 125I-Ro16-0154: Potential probe for spect brain imagingLife Sciences, 1990
- Pharmacokinetics of the new benzodiazepine antagonist Ro 15‐1788 in man following intravenous and oral administration.British Journal of Clinical Pharmacology, 1986
- Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in manEuropean Journal of Clinical Pharmacology, 1984
- Characterization of the binding of benzodiazepines to human serum albuminNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973